Atlas Trials

Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

Clinical trial NCT04533243 · UNKNOWN

Trial details

NCT number
NCT04533243
Sponsor
Fujian Cancer Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive
Start date
2020-09-01
Primary completion
2022-08-31
Enrollment
209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.